Silva Maria Elena, Lange Simona, Hinrichsen Bryan, Philp Amber R, Reyes Carolina R, Halabi Diego, Mansilla Josselyne B, Rotheneichner Peter, Guzman de la Fuente Alerie, Couillard-Despres Sebastien, Bátiz Luis F, Franklin Robin J M, Aigner Ludwig, Rivera Francisco J
Laboratory of Stem Cells and Neuroregeneration, Institute of Anatomy, Histology and Pathology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile.
Center for Interdisciplinary Studies on the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile.
Front Cell Neurosci. 2019 Mar 27;13:85. doi: 10.3389/fncel.2019.00085. eCollection 2019.
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Upon demyelination, oligodendrocyte progenitor cells (OPCs) are activated and they proliferate, migrate and differentiate into myelin-producing oligodendrocytes. Besides OPCs, neural stem cells (NSCs) may respond to demyelination and generate oligodendrocytes. We have recently shown that CNS-resident pericytes (PCs) respond to demyelination, proliferate and secrete Laminin alpha2 (Lama2) that, in turn, enhances OPC differentiation. Here, we aimed to evaluate whether PCs influence the fate choice of NSCs , towards the production of new myelin-producing cells. Indeed, upon exposure to conditioned medium derived from PCs (PC-CM), the majority of NSCs gave rise to GalC- and myelin basic protein (MBP)-expressing oligodendrocytes at the expense of the generation of GFAP-positive astrocytes. Consistent with these findings, PC-CM induces an increase in the expression of the oligodendrocyte fate determinant Olig2, while the expression level of the astrocyte determinant ID2 is decreased. Finally, pre-incubation of PC-CM with an anti-Lama2 antibody prevented the generation of oligodendrocytes. Our findings indicate that PCs-derived Lama2 instructs NSCs to an oligodendrocyte fate choice favoring the generation of myelin-producing cells at the expense of astrocytes . Further studies aiming to reveal the role of PCs during remyelination may pave the way for the development of new therapies for the treatment of MS.
多发性硬化症(MS)是一种中枢神经系统(CNS)的炎性脱髓鞘疾病。脱髓鞘发生时,少突胶质前体细胞(OPC)被激活,它们增殖、迁移并分化为产生髓磷脂的少突胶质细胞。除了OPC,神经干细胞(NSC)也可能对脱髓鞘作出反应并生成少突胶质细胞。我们最近发现,中枢神经系统驻留的周细胞(PC)对脱髓鞘有反应,增殖并分泌层粘连蛋白α2(Lama2),进而增强OPC的分化。在此,我们旨在评估PC是否会影响NSC的命运选择,使其朝着产生新的髓磷脂生成细胞的方向发展。实际上,在接触源自PC的条件培养基(PC-CM)后,大多数NSC产生了表达半乳糖脑苷脂(GalC)和髓磷脂碱性蛋白(MBP)的少突胶质细胞,而生成GFAP阳性星形胶质细胞的数量减少。与这些发现一致,PC-CM诱导少突胶质细胞命运决定因子Olig2的表达增加,而星形胶质细胞决定因子ID2的表达水平降低。最后,用抗Lama2抗体对PC-CM进行预孵育可阻止少突胶质细胞的生成。我们的研究结果表明,源自PC的Lama2引导NSC选择少突胶质细胞命运,有利于生成髓磷脂生成细胞,而以牺牲星形胶质细胞为代价。旨在揭示PC在髓鞘再生过程中作用的进一步研究可能为开发治疗MS的新疗法铺平道路。